Natixis supports the fight against malaria

Paris, France, April 24, 2012

On the occasion of World Malaria Day on April 25, Natixis confirmed its 8-year commitment to the fight against this disease which still claims close to one million lives every year throughout the world.

Natixis’ long-lasting commitment to the fight against malaria is twofold: active support of malaria prevention programs in endemic areas and financing of research carried out by Institut Pasteur.

Actions in the field

Since 2005, Natixis has been active in the field and has financed awareness programs for the population, the distribution of mosquito nets and antimalarial treatment to the most vulnerable, i.e. pregnant women and young children.

For instance, Natixis has supported three major programs set up by Plan France in Cameroon, Burkina Faso and in Togo. In these three countries, a total of 75,100 mosquito nets were distributed, thus protecting the lives of 45,900 children under 5 and 46,000 pregnant women.

The latest survey1 of the program set up in Togo showed significant results:

  • 86% of households owned an insecticide-treated mosquito net in 2010 (18% in 2004);
  • 89% of children under sleep with a mosquito net (10% in 2004);
  • 95% of pregnant women have received antimalarial treatment.

 

Support of research programs

Natixis also finances research carried out by Institut Pasteur on the resistance of parasites to malaria drugs, a serious issue according to WHO.

The purpose of this research, carried out in collaboration with Institut Pasteur in Cambodia, is to understand the reasons for this parasite resistance, to come up with alternative treatments and prevent their dissemination.

 

Based on these results, Natixis has renewed its commitment for 2012/2013:

  • alongside Plan France (www.planfrance.org) in Togo, with a new program for the increase of medication endowment and the consolidation of health worker skills;
  • with Institut Pasteur (www.pasteur.fr), with a new research on the resistance of malaria parasites to artemisinin-based medication.

 

Through these actions, Natixis commits on the long term to fair development and contributes to the Millenium Development Goals (MDG) for 2015 in three areas: to reduce child mortality, improve maternal health and combat HIV/AIDS, malaria and other diseases.

Malaria still claims close to one million lives every year, according to WHO, mainly of pregnant women and young children. Two million people, i.e. 40% of the world’s population, including 90% in Africa, are exposed to the disease.

Thanks to prevention (use of insecticide-treated mosquito nets), diagnosis and treatment means, considerable progress has been made in several countries: the death of 1.1 million children has been prevented in Africa since 2000 and 20102.

 

2Roll back Malaria Report – “A decade of Partnership and Results”

To secure its communication, contents are certified on the blockchain using Wiztrust

Attachments

Contacts